ViaCyte, a beta cell technology company funded by JDRF, has been awarded a Small Business Innovative Research (SBIR) Phase II Award from the National Institute
JDRF’s One Walks are taking place across the UK, giving you the chance to help raise money for Type 1 diabetes research. A global event
The Ascensia Diabetes Challenge was launched last September. A global innovation competition, it was introduced to fine digital solutions to support Type 2 diabetes management.
As reported in Fierce Biotech, in America Semma Therapeutics has raised $114 million to take a potentially-curative Type 1 diabetes cell therapy through clinical proof
Researchers at Leeds Beckett University are seeking volunteers with Type 1 diabetes to take part in a new study looking to determine whether omega-3 supplements
Diabetes kit that’s coming soon: An interview with Dr. Philip Toleikis of Sernova Corp, based in London, Ontario, Canada about the company’s Cell Pouch and
The BiAP is the bio-inspired artificial pancreas. We have an update on progress of this British-based endeavour. Moving overseas, we have another research report on
A new way of holding insulin producing islet cells inside the body has been developed at the Royal Adelaide Hospital in southern Australia, where doctors
Researchers at Lund University in Sweden have found a new type of biomarker that can predict the risk of Type 2 diabetes, by detecting epigenetic
A glucogen powder now in development by Eli Lilly to treat dangerously low blood sugar in patients with Type 1 diabetes, the goal being to
